Corneal Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-07-08
EMA Authorised: Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells) — Holostem s.r.l.
The European Medicines Agency authorised Holoclar, an autologous stem cell-based therapy for repairing the corneal surface in patients with …